Cargando…

Itaconate and fumarate derivatives inhibit priming and activation of the canonical NLRP3 inflammasome in macrophages

The NLRP3 inflammasome is a multiprotein complex that regulates caspase‐1 activation and subsequent interleukin (IL)‐1β and IL‐18 release from innate immune cells in response to infection or injury. Derivatives of the metabolites itaconate and fumarate, dimethyl itaconate (DMI), 4‐octyl itaconate (4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoyle, Christopher, Green, Jack P., Allan, Stuart M., Brough, David, Lemarchand, Eloise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426622/ https://www.ncbi.nlm.nih.gov/pubmed/35137954 http://dx.doi.org/10.1111/imm.13454

Ejemplares similares

Hallmarks of NLRP3 inflammasome activation are observed in organotypic hippocampal slice culture
por: Hoyle, Christopher, et al.
Publicado: (2020)

Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome
por: Lemarchand, Eloise, et al.
Publicado: (2019)

The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
por: Hooftman, Alexander, et al.
Publicado: (2020)

Itaconate confers tolerance to late NLRP3 inflammasome activation
por: Bambouskova, Monika, et al.
Publicado: (2021)

Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages
por: Song, Mei-yue, et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

The NLRP3–inflammasome as a sensor of organelle dysfunction
por: Seoane, Paula I., et al.
Publicado: (2020)

Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
por: Gritsenko, Anna, et al.
Publicado: (2020)

Mechanisms of NLRP3 priming in inflammaging and age related diseases
por: Gritsenko, Anna, et al.
Publicado: (2020)

4-Octyl-itaconate and dimethyl fumarate inhibit COX2 expression and prostaglandin production in macrophages
por: Diskin, Ciana, et al.
Publicado: (2021)

Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
por: Nizami, Sohaib, et al.
Publicado: (2020)

Corrigendum: Priming Is Dispensable for NLRP3 Inflammasome Activation in Human Monocytes In Vitro
por: Gritsenko, Anna, et al.
Publicado: (2021)

Itaconate Attenuates Neuroinflammation and Exerts Dopamine Neuroprotection in Parkinson’s Disease through Inhibiting NLRP3 Inflammasome
por: Sun, Guoqing, et al.
Publicado: (2022)

Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages
por: Zhu, Kaixiang, et al.
Publicado: (2021)

Itaconate Suppresses the Activation of Mitochondrial NLRP3 Inflammasome and Oxidative Stress in Allergic Airway Inflammation
por: Xie, Qiu-Meng, et al.
Publicado: (2023)

Mercury and arsenic attenuate canonical and non-canonical NLRP3 inflammasome activation
por: Ahn, Huijeong, et al.
Publicado: (2018)

Corticosterone Inhibits LPS-Induced NLRP3 Inflammasome Priming in Macrophages by Suppressing Xanthine Oxidase
por: Wu, Ling, et al.
Publicado: (2020)

Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages
por: Swain, Amanda, et al.
Publicado: (2020)

Salmonella Flagellin Activates NAIP/NLRC4 and Canonical NLRP3 Inflammasomes in Human Macrophages
por: Gram, Anna M., et al.
Publicado: (2021)

Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages
por: Luheshi, Nadia M, et al.
Publicado: (2012)

Novel perspectives on non-canonical inflammasome activation
por: Diamond, Catherine Emma, et al.
Publicado: (2015)

DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages
por: de Vasconcelos, Nathalia M, et al.
Publicado: (2019)

Bafilomycin A1 enhances NLRP3 inflammasome activation in human monocytes independent of lysosomal acidification
por: Yu, Shi, et al.
Publicado: (2020)

Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
por: Ryan, Tristram A. J., et al.
Publicado: (2023)

Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages
por: Nolan, R.A., et al.
Publicado: (2019)

USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation
por: Palazón‐Riquelme, Pablo, et al.
Publicado: (2018)

Boron-Based Inhibitors of the NLRP3 Inflammasome
por: Baldwin, Alex G., et al.
Publicado: (2017)

NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury
por: Savage, Catherine Diane, et al.
Publicado: (2012)

NLRP3 Inflammasome Priming and Activation Are Regulated by a Phosphatidylinositol-Dependent Mechanism
por: Hamilton, Claire, et al.
Publicado: (2022)

Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation
por: Pellegrini, Carolina, et al.
Publicado: (2017)

Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon
por: Ryan, Tristram A. J., et al.
Publicado: (2023)

The NLRP3 inflammasome in macrophages is stimulated by cell‐free hemoglobin
por: Shaver, Ciara M., et al.
Publicado: (2020)

Mesenchymal Stromal Cells Directly Promote Inflammation by Canonical NLRP3 and Non-canonical Caspase-11 Inflammasomes
por: Chen, Yaozhen, et al.
Publicado: (2018)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

Chemotherapeutic Agent Paclitaxel Mediates Priming of NLRP3 Inflammasome Activation
por: Son, Seunghwan, et al.
Publicado: (2019)

Optimized Bioproduction of Itaconic and Fumaric Acids Based on Solid-State Fermentation of Lignocellulosic Biomass
por: Jiménez-Quero, Amparo, et al.
Publicado: (2020)

Post-transcriptional control of NLRP3 inflammasome activation in colonic macrophages
por: Filardy, Alessandra A., et al.
Publicado: (2015)

Maltol, a Natural Flavor Enhancer, Inhibits NLRP3 and Non-Canonical Inflammasome Activation
por: Ahn, Huijeong, et al.
Publicado: (2022)

Itaconate: A Potent Macrophage Immunomodulator
por: Li, Zeyu, et al.
Publicado: (2023)

S1P/S1P(2) Signaling Axis Regulates Both NLRP3 Upregulation and NLRP3 Inflammasome Activation in Macrophages Primed with Lipopolysaccharide
por: Lee, Chi-Ho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n27r0o8meip7bcso9in6kgl59b